Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
August 16, 2023
Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer’s disease, according to new research from UTHealth Houston.
August 11, 2023
A clinical trial evaluating the role of statins in the risk of recurrent intracerebral hemorrhage (ICH) in patients presenting with ICH, has opened for enrollment at UTHealth Houston.
August 8, 2023
A five-year, $3.1 million grant to study preventive strategies for sudden unexpected death in epilepsy (SUDEP) has been awarded to UTHealth Houston by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke.
August 1, 2023
The new UT Physicians Interventional Psychiatry Clinic provides services for patients with treatment-resistant psychiatric conditions in one location. Its goal is to not only embrace the current interventional psychiatry services but also expand and develop new services.
July 31, 2023
Two clinical trials that will evaluate drugs, biologics, medical devices, and other therapies for long COVID that are sponsored by the National Institutes of Health (NIH) will launch at UTHealth Houston.
July 19, 2023
The incidences of teen suicidality including self-harm, suicidal ideation, and suicide attempts increased nationally between 2016 and 2021; were at seasonal high peaks in April and October; and were at their lowest when schools were shut down during the COVID-19 pandemic, according to research at UTHealth Houston.
July 14, 2023
UTHealth Houston School of Public Health researchers will participate in a national initiative to help combat cancer disparities fueled by persistent poverty. The five-year grant was awarded to collaborators at The University of Texas MD Anderson Cancer Center from the National Cancer Institute, part of the National Institutes of Health. Nearing $10 million in funding for five years, UTHealth Houston researchers will receive nearly $2 million as co-investigators to foster cancer prevention research and strengthen community-based programs in low-income areas.
July 7, 2023
A novel molecular pathway to explain how a mutation in the gene ACTA2 can cause individuals in their 30s – with normal cholesterol levels and no other risk factors — to develop coronary artery disease has been identified, according to researchers with UTHealth Houston.
July 6, 2023
Versil Joyles-Stapleton, 76, can’t seem to slow herself down — a drastic change to how she lived her life just 2 years ago.
July 5, 2023
People who are regular cannabis users are at an increased risk of experiencing complications before, during, and after surgery, according to a study by researchers with UTHealth Houston published today in JAMA Surgery.
Use the form below to perform a new search.